First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors
First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors
Not yet recruiting · NCT06134531 · Registry updated 2023-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-In-Human Study of Bispecific Antibody MR001 In Subjects With Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2023-11-18 | NCT06134531 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 248 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 2 |